MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling (PRS) company, today announced a strategic partnership with ...
The second edition of the NUHS Scientific and Innovation Summit underscores how data and genetic insight is transforming health, with launch of the National University Centre for Genomic Medicine a ...
Screening for glaucoma and estimating risk could get much more precise with advances underway in genomics and AI. These advances are helping experts understand the many complexities of glaucoma, ...
Quest's Infrastructure to Enable Access to HelioLiver(TM) , an AI-Powered, Blood-Based Test for Early Detection of Liver Cancer IRVINE, Calif., March 18, 2026 /PRNewswire/ -- Helio Genomics, an ...
When her doctor died suddenly in August, Tammy MacDonald found herself among the roughly 17% of adults in America without a primary care physician. MacDonald needed to find a new doctor right away.
As healthcare providers increasingly adopt artificial intelligence tools, researchers, physicians and health tech companies are moving quickly to assess the verifiable impact of these technologies.
When her doctor died suddenly in August, Tammy MacDonald found herself among the roughly 17% of adults in America without a primary care physician. MacDonald wanted to find a new doctor right away.